Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | RGS12 | O14924 | 1/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | GLS | O94925 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29459619 | 1.00 | KDM4E (0.68) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL8632419 | 0.96 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL2554681 | 0.94 | KDM4E (0.72) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL3468673 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL17275126 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL7296911 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL1448490 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL7352888 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL4179085 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A | |
| SCHEMBL7544499 | 0.92 | KDM4E (0.70) | KDM4EALDH1A1MEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390724-A | Synthesis method of phosphorous acid diester compound | 兰州大学 | 2025-02-07 | — | — | CN | claimed |
| CN-111116453-B | Preparation method of N- (3-hydroxypropyl) phthalimide and catalyst used for method | 万华化学集团股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| US-20240209278-A1 | AMINE-BOOSTED DETERGENT | CHEVRON ORONITE COMPANY LLC | 2024-06-27 | — | — | US | claimed |
| EP-4352188-A1 | AMINE-BOOSTED DETERGENT | Chevron Oronite Company LLC (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117597421-A | Amine enhanced detergents | 雪佛龙奥伦耐有限责任公司 | 2024-02-23 | — | — | CN | claimed |
| CN-114196023-B | Surface modifier and application thereof in preparation of silicon-based composite functional coating material | 中材高新江苏硅材料有限公司 | 2022-12-20 | — | — | CN | claimed |
| WO-2022259193-A1 | AMINE-BOOSTED DETERGENT | CHEVRON ORONITE COMPANY LLC (US) | 2022-12-15 | — | — | WO | claimed |
| CN-114196023-A | Surface modifier and application thereof in preparation of silicon-based composite functional coating material | 中材高新江苏硅材料有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-111116453-A | Preparation method of N- (3-hydroxypropyl) phthalimide and catalyst used in method | 万华化学集团股份有限公司 | 2020-05-08 | — | — | CN | claimed |
| US-6187083-B1 | INK COMPOSITION COMPRISING SELECTED INK VEHICLE, AMIDE VISCOSITY MODIFIER, CONDUCTIVE SULFONATE SALT ALL HAVING MELTING POINTS WITHIN SPECIFIED RANGE, COLORANT, OPTIONAL ANTIOXIDANT AND ULTRAVIOLET ABSORBER | XEROX CORPORATION | 2001-02-13 | — | — | US | claimed |
| EP-3886904-B1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12479858-B2 | Macrocyclic compounds as sting agonists and methods and uses thereof | LUPIN LIMITED (IN) | 2025-11-25 | — | — | US | disclosed |
| CN-223096890-U | Grinding device of N- (3-hydroxypropyl) phthalimide | 大连金点生物科技有限公司 | 2025-07-15 | — | — | CN | disclosed |
| CN-223096890-U | Grinding device of N- (3-hydroxypropyl) phthalimide | 大连金点生物科技有限公司 | 2025-07-15 | — | — | CN | disclosed |
| US-12338210-B2 | Degradable polymers and monomers therefor | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-06-24 | — | — | US | disclosed |
| WO-1986000902-A1 | DERIVATIVES OF METHYLENE-BISPHOSPHONIC ACID, PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 1986-02-13 | — | — | WO | disclosed |
| US-4395417-A | Antihyperlipidemic compositions | RESEARCH CORPORATION (US) | 1983-07-26 | — | — | US | disclosed |
| US-4211703-A | CHEMICAL INTERMEDIATES FOR CEPHALOSPORINS | SMITHKLINE CORPORATION (US) | 1980-07-08 | — | — | US | disclosed |
| US-4189573-A | CHEMICAL INTERMEDIATES | SMITHKLINE CORPORATION (US) | 1980-02-19 | — | — | US | disclosed |
| US-4112086-A | BACTERICIDE | SMITHKLINE CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479858-B2 | Macrocyclic compounds as sting agonists and methods and uses thereof | STING1, CGAS, MAVS | KDM4E 4476/4885ALDH1A1 4861/4885MEN1 1550/4885 |
| US-12338210-B2 | Degradable polymers and monomers therefor | HDHD5, LTA4H, KYNU | KDM4E 487/4885ALDH1A1 168/4885MEN1 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.